Skip Navigation
Menu
Letters |2 July 2013

Successful Treatment of the Postpartum Atypical Hemolytic Uremic Syndrome With Eculizumab

Stefan Zschiedrich, MD; Eric P. Prager, MD; E. Wolfgang Kuehn, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • From University Hospital Freiburg, Freiburg, Germany.

    Potential Conflicts of Interest: Other (money to institution): Alexion Pharmaceuticals.

×
FULL TEXT
Background: Thrombocytopenia with intravascular hemolysis is a serious complication of pregnancy. When it occurs in the second and third trimesters, it is usually associated with near-absent levels of the ADAMTS13 protease that cleaves von Willebrand factor, a condition that is typical of idiopathic thrombotic thrombocytopenic purpura (1). During pregnancy, approximately 50% of cases of thrombotic thrombocytopenic purpura result in perinatal fetal loss and maternal mortality is also substantial, although plasma exchange has reduced maternal mortality from 58% before 1980 to 9% after 1996 (1). In contrast, when thrombocytopenia with intravascular hemolysis occurs in the postpartum period, ADAMTS13 activity...
FULL TEXT
PDF
Not Available
Citations
Citation

Zschiedrich S, Prager EP, Kuehn EW. Successful Treatment of the Postpartum Atypical Hemolytic Uremic Syndrome With Eculizumab. Ann Intern Med. 2013;159:76. doi: 10.7326/0003-4819-159-1-201307020-00023

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2013;159(1):76.

DOI: 10.7326/0003-4819-159-1-201307020-00023

19 Citations

Related Articles
Update in Nephrology: Evidence Published in 2011
Annals of Internal Medicine; 157 (3): 192-196
Distinguishing Case Series From Cohort Studies
Annals of Internal Medicine; 156 (1_Part_1): 37-40
Trends in the Incidence of Venous Thromboembolism during Pregnancy or Postpartum: A 30-Year Population-Based Study
Annals of Internal Medicine; 143 (10): 697-706
Quinine-Associated Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome: Frequency, Clinical Features, and Long-Term Outcomes
Annals of Internal Medicine; 135 (12): 1047-1051
View MoreView Less

Related Topics
Hematology/Oncology
Nephrology
Platelet Disorders
Red Cell Disorders

Hematology/Oncology, Nephrology, Platelet Disorders, Red Cell Disorders.

PubMed Articles
Prodromal Phase of Hemolytic Uremic Syndrome Related to Shiga Toxin-Producing Escherichia coli: The Wasted Time.
Pediatr Emerg Care 2019.
Dynamic Gene Network Analysis of Caco-2 Cell Response to Shiga Toxin-Producing Escherichia coli-Associated Hemolytic-Uremic Syndrome.
Microorganisms 2019;7(7):.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×